Both IGF1 and G‐CSF have been implicated in influencing dormant cell behavior; specifically, IGF1 administration promotes proliferation of dormant breast cancer cells, as evidenced by increased Ki67+ DCCs [338]. Here, MKI67 is linked to breast cancer.